Back to Search
CAROL TIERNEY, PH.D.
PH.D.
Clinical Psychologist
NPI: 1316033384Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
1036(CO)
Research & Publications (18)
Osteoblast activity on collagen-GAG scaffolds is affected by collagen and GAG concentrations.
PMID 18767061·J Biomed Mater Res A·2009
7-preclinical
The effects of collagen concentration and crosslink density on the biological, structural and mechanical properties of collagen-GAG scaffolds for bone tissue engineering.
PMID 19627824·J Mech Behav Biomed Mater·2009
7-preclinical
Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics.
PMID 14595049·Pediatrics·2003
8-other
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.
PMID 19597072·Arch Intern Med·2009
4-observational
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects.
PMID 17452489·Antimicrob Agents Chemother·2007
3-trial
Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
PMID 16425127·J Infect Dis·2006
8-other
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.
PMID 16392089·Clin Infect Dis·2006
8-other
Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results.
PMID 15668539·AIDS·2005
3-trial
Sleep complaints, subjective and objective sleep patterns, health, psychological adjustment, and daytime functioning in community-dwelling older adults.
PMID 15980285·J Gerontol B Psychol Sci Soc Sci·2005
8-other
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.
PMID 15622315·AIDS·2004
3-trial
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.
PMID 12508159·J Infect Dis·2003
3-trial
Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).
PMID 12905142·Clin Infect Dis·2003
8-other
A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298).
PMID 12167276·AIDS Res Hum Retroviruses·2002
3-trial
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
PMID 11709782·J Infect Dis·2001
3-trial
Considerations in choosing a primary endpoint that measures durability of virological suppression in an antiretroviral trial.
PMID 10997401·AIDS·2000
8-other
In vivo antagonism with zidovudine plus stavudine combination therapy.
PMID 10882616·J Infect Dis·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4770 BASELINE ROAD, SUITE 300
BOULDER, CO 80303 - Phone
- (303) 440-9513
Quick Facts
- NPI
- 1316033384
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile